JP2021525266A5 - - Google Patents
Info
- Publication number
- JP2021525266A5 JP2021525266A5 JP2020565864A JP2020565864A JP2021525266A5 JP 2021525266 A5 JP2021525266 A5 JP 2021525266A5 JP 2020565864 A JP2020565864 A JP 2020565864A JP 2020565864 A JP2020565864 A JP 2020565864A JP 2021525266 A5 JP2021525266 A5 JP 2021525266A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1808564.7A GB201808564D0 (en) | 2018-05-24 | 2018-05-24 | Treatments |
| GB1808564.7 | 2018-05-24 | ||
| PCT/IB2019/054292 WO2019224779A1 (en) | 2018-05-24 | 2019-05-23 | Lopinavir and ritonavir for the treatment of cervix disorders |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021525266A JP2021525266A (ja) | 2021-09-24 |
| JPWO2019224779A5 JPWO2019224779A5 (https=) | 2023-07-19 |
| JP2021525266A5 true JP2021525266A5 (https=) | 2023-07-19 |
| JP7344911B2 JP7344911B2 (ja) | 2023-09-14 |
Family
ID=62812406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020565864A Active JP7344911B2 (ja) | 2018-05-24 | 2019-05-23 | 頸部障害の処置のためのロピナビルおよびリトナビル |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11738024B2 (https=) |
| EP (1) | EP3801509A1 (https=) |
| JP (1) | JP7344911B2 (https=) |
| CN (1) | CN112203656B (https=) |
| AU (1) | AU2019274812B2 (https=) |
| BR (1) | BR112020023964A2 (https=) |
| CA (1) | CA3100425A1 (https=) |
| GB (1) | GB201808564D0 (https=) |
| MX (1) | MX2020012656A (https=) |
| SG (1) | SG11202010138WA (https=) |
| WO (1) | WO2019224779A1 (https=) |
| ZA (1) | ZA202006324B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201808563D0 (en) | 2018-05-24 | 2018-07-11 | Univ Manchester | Treatments |
| GB201808564D0 (en) | 2018-05-24 | 2018-07-11 | Douglas Pharmaceuticals Ltd | Treatments |
| GB201907305D0 (en) | 2019-05-23 | 2019-07-10 | Douglas Pharmaceuticals Ltd | Treatment of conditions |
| GB201917252D0 (en) * | 2019-11-27 | 2020-01-08 | Pharmaceutic compositions |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8822857D0 (en) | 1988-09-29 | 1988-11-02 | Patralan Ltd | Pharmaceutical formulations |
| DK2269591T3 (en) * | 2000-01-19 | 2018-07-16 | Abbvie Inc | IMPROVED PHARMACEUTICAL FORMULATIONS |
| CA2445967A1 (en) | 2001-05-01 | 2002-11-07 | Abbott Laboratories | Compositions comprising lopinavir and methods for enhancing the bioavailability of pharmaceutical agents |
| US20030129208A1 (en) | 2002-01-07 | 2003-07-10 | Alberts David S. | Topical application of alpha-DFMO and anti-inflammatory drug for treatment of actinic keratoses |
| WO2004010937A2 (en) | 2002-07-26 | 2004-02-05 | Advanced Research & Technology Institute At Indiana University | Method of treating cancer |
| BR0302523A (pt) | 2003-07-23 | 2005-04-05 | Cristalia Prod Quimicos Farm | Composição farmacêutica estável para administração de inibidores da hiv protease e processo de obtenção de composição farmacêutica concentrada para a administração de inibidores da hiv protease |
| US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
| CA2582559A1 (en) | 2003-11-28 | 2005-06-16 | The University Of Manchester | Treatment of hpv infections and cancer |
| WO2008088806A1 (en) | 2007-01-16 | 2008-07-24 | Johns Hopkins University | Combinational paradigm combating hiv, hiv/hsv, or hiv/hpv infections in humans using small molecular weight compounds from plants |
| EP2280690A2 (en) | 2008-04-18 | 2011-02-09 | Nanobio Corporation | Methods for treating herpes virus infections |
| GB201006038D0 (en) | 2010-04-12 | 2010-05-26 | Unilever Plc | Improvements relating to antiviral compositions |
| KR20130139896A (ko) | 2010-09-08 | 2013-12-23 | 프로노바 바이오파마 너지 에이에스 | 유리산 형태의 epa 및 dha, 계면활성제, 및 스타틴을 포함하는 조성물 |
| GB201115635D0 (en) | 2011-09-09 | 2011-10-26 | Univ Liverpool | Compositions of lopinavir and ritonavir |
| PL3060211T3 (pl) | 2013-10-23 | 2020-07-27 | The University Of Manchester | Leczenie nowotworu i łagodnych chorób proliferacyjnych |
| WO2016123541A2 (en) | 2015-01-30 | 2016-08-04 | Tobira Therapeutics, Inc. | Cenicriviroc for the treatment of encephalitis infection |
| WO2019130341A1 (en) | 2017-12-26 | 2019-07-04 | Hetero Labs Limited | Capsule compositions comprising lopinavir and ritonavir |
| GB201808563D0 (en) | 2018-05-24 | 2018-07-11 | Univ Manchester | Treatments |
| GB201808564D0 (en) | 2018-05-24 | 2018-07-11 | Douglas Pharmaceuticals Ltd | Treatments |
| GB201808567D0 (en) | 2018-05-24 | 2018-07-11 | Douglas Pharmaceuticals Ltd | Pharmaceutical compositions |
| GB201808571D0 (en) | 2018-05-24 | 2018-07-11 | Douglas Pharmaceuticals Ltd | Pharmaceutical compositions |
| GB201907305D0 (en) | 2019-05-23 | 2019-07-10 | Douglas Pharmaceuticals Ltd | Treatment of conditions |
| GB201917252D0 (en) | 2019-11-27 | 2020-01-08 | Pharmaceutic compositions |
-
2018
- 2018-05-24 GB GBGB1808564.7A patent/GB201808564D0/en not_active Ceased
-
2019
- 2019-05-23 CN CN201980034993.5A patent/CN112203656B/zh active Active
- 2019-05-23 CA CA3100425A patent/CA3100425A1/en active Pending
- 2019-05-23 MX MX2020012656A patent/MX2020012656A/es unknown
- 2019-05-23 AU AU2019274812A patent/AU2019274812B2/en active Active
- 2019-05-23 US US17/055,048 patent/US11738024B2/en active Active
- 2019-05-23 BR BR112020023964-0A patent/BR112020023964A2/pt unknown
- 2019-05-23 WO PCT/IB2019/054292 patent/WO2019224779A1/en not_active Ceased
- 2019-05-23 EP EP19732473.4A patent/EP3801509A1/en active Pending
- 2019-05-23 JP JP2020565864A patent/JP7344911B2/ja active Active
- 2019-05-23 SG SG11202010138WA patent/SG11202010138WA/en unknown
-
2020
- 2020-10-12 ZA ZA2020/06324A patent/ZA202006324B/en unknown
-
2023
- 2023-06-30 US US18/216,937 patent/US20240148729A1/en active Pending